Becton Dickinson and Co BDX:NYSE

RT Quote | NYSE | USD
Last | 03/04/21 EST
240.88quote price arrow down-0.78 (-0.32%)
Volume
1,326,561
52 week range
197.75 - 284.97

...

Loading . . .

KEY STATS

  • Open241.82
  • Day High243.88
  • Day Low238.46
  • Prev Close240.88
  • 52 Week High284.97
  • 52 Week High Date08/05/20
  • 52 Week Low197.75
  • 52 Week Low Date03/23/20
  • Market Cap69.99B
  • Shares Out290.56M
  • 10 Day Average Volume1.44M
  • Dividend3.32
  • Dividend Yield1.38%
  • Beta0.78
  • 1 Year % Change-2.52

RATIOS/PROFITABILITY

  • EPS (TTM)5.20
  • P/E (TTM)46.30
  • Fwd P/E (NTM)21.06
  • EBITDA (MRQ)5.465B
  • ROE (MRQ)6.58%
  • Revenue (MRQ)18.207B
  • Gross Margin (MRQ)46.30%
  • Net Margin (MRQ)8.79%
  • Debt To Equity (MRQ)72.25%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date03/09/2021
  • Div Amount0.83
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business...
Vincent Forlenza
Chairman
Thomas Polen
Chairman
Christopher Reidy
Chief Financial Officer
Simon Campion
Executive Vice President
Alexandre Conroy
Executive Vice President
Address
1 Becton Dr
Franklin Lakes, NJ
07417-1815
United States